Rilonacept (interleukin-1 trap) for prevention of gout flares during initiation of uric acid–lowering therapy: Results from a phase III randomized, double-blind, placebo-controlled, confirmatory efficacy study

✍ Scribed by H. Ralph Schumacher Jr.; Robert R. Evans; Kenneth G. Saag; James Clower; William Jennings; Steven P. Weinstein; George D. Yancopoulos; Jian Wang; Robert Terkeltaub

• Book ID: 115548530
• Publisher: Wiley (John Wiley & Sons)
• Year: 2012
• Tongue: English
• Weight: 188 KB
• Volume: 64
• Category: Article
• ISSN: 2151-464X
• DOI: 10.1002/acr.21690